What about a software that could enhance homogeneity and connection between oncologists and the radiologists?

With a standardize data production of solid tumor evolution, following international guidelines, ON’COHUB™ is a solution that focuses on the patient journey to improve trial and routine practice.

ON’COHUB™

Expected benefits

Data standardization

Data production according to international guidelines (RECIST 1.1, iRECIST) and compliant with Good Clinical Practices by design Generate standardized and automated reports

Real-time sharing capabilities

Access to treatment response data Access granted to the practicing medical team as well as research stakeholders

Patient-centric

Adapted for patients in clinical trials and routine Access to patient’s treatment history

MANDATORY NOTICES:

ON’COHUB™ is a clinical decision support software as a service designed to facilitate monitoring of the evolution of the size of solid tumors in cancer patients. For more information, please refer to the user manual, available on demand. You can also contact WeHealth™ Digital Medicine or your local representative, if you have one.

EU: ON’COHUB™ is a class I CE marked medical device. Information notice: ON’COHUB™ is not available in France. For more information about the solution in France, contact the manufacturer DeepLink Medical directly.

ON’COHUB™ is also known as OCELIAN™ in the US. US: ON’COHUB™ is a clinical decision support software, not considered as a medical device, in application to section 520 of 21st Century Cures Act (Cures Act).